Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device

BACKGROUND: Several extracorporeal carbon dioxide removal (ECCO(2)R) devices are currently in use with variable efficacy and safety profiles. PrismaLung+ is an ECCO(2)R device that was recently introduced into clinical practice. It is a minimally invasive, low flow device that provides partial respi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tiruvoipati, Ravindranath, Ludski, Jarryd, Gupta, Sachin, Subramaniam, Ashwin, Ponnapa Reddy, Mallikarjuna, Paul, Eldho, Haji, Kavi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436516/
https://www.ncbi.nlm.nih.gov/pubmed/37596670
http://dx.doi.org/10.1186/s40001-023-01269-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10436516/
https://www.ncbi.nlm.nih.gov/pubmed/37596670
http://dx.doi.org/10.1186/s40001-023-01269-2

Ejemplares similares